Thiogenesis Therapeutics, Corp. (TSXV:TTI)
0.6200
-0.0100 (-1.59%)
Dec 5, 2025, 2:00 PM EST
-3.13% (1Y)
| Market Cap | 32.66M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -6.82M |
| Shares Out | 51.84M |
| EPS (ttm) | -0.14 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 26,155 |
| Open | 0.6100 |
| Previous Close | 0.6300 |
| Day's Range | 0.5800 - 0.6200 |
| 52-Week Range | 0.5100 - 0.8800 |
| Beta | 0.58 |
| RSI | 43.83 |
| Earnings Date | Nov 17, 2025 |